BioPlus Acquisition Other Current Liabilities

BioPlus Acquisition (BIOS) currently reports a other current liabilities of $1.7M as of June 2023. That compares with $-180K in the prior-year period — up 1064.4% year over year. Use the charts on this page to explore BioPlus Acquisition's other current liabilities history and peer comparisons.

BioPlus Acquisition's other current liabilities increased from $-180K to $1.7M — a 1064.4% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioPlus Acquisition reported $1.7M in other current liabilities as of June 2023. That compares with $-180K in the prior-year period — up 1064.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $1.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioPlus Acquisition, and consider following BIOS for alerts when major investors trade the stock.